HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hillel Laks Davis C. Drinkwater, Jr. Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brauner, R. Articles by Wang, J.-L. Search for Related Content PubMed PubMed Citation Articles by Brauner, R. Articles by Wang, J.-L.

J Thorac Cardiovasc Surg 1997;113:1059-1067
© 1997 Mosby, Inc.

CARDIAC AND PULMONARY REPLACEMENT

INTRACORONARY GENE TRANSFER OF IMMUNOSUPPRESSIVE CYTOKINES TO CARDIAC ALLOGRAFTS: METHOD AND EFFICACY OF ADENOVIRUS-MEDIATED TRANSDUCTION

Received for publication July 3, 1996 revisions requested Sept. 19, 1996; revisions received Oct. 21, 1996 accepted for publication Dec. 13, 1996. Address for reprints: Hillel Laks, MD, Division of Cardiothoracic Surgery, UCLA Medical Center, 62-182A Center for the Health Sciences, 10833 Le Conte Ave., Los Angeles, CA 90095.

Abstract

Objective:Allograft-targeted immunosuppressive gene therapy may inhibit recipient immune activation and provide an alternative to systemic immunosuppression. We studied the optimal technique and efficacy of intracoronary gene transfer of viral interleukin-10 and human transforming growth factor–ß₁ in a rabbit model of heterotopic heart transplantation. Methods: Replication-defective adenoviral vectors were constructed, expressing viral interleukin-10 (AdSvIL10) or transforming growth factor–ß₁ (AdCMVTGF-ß₁). Intracoronary delivery of vectors was accomplished ex vivo by either bolus injection or slow infusion. The allografts were implanted heterotopically in recipient rabbits and collected 4 days after the operation. Vector dose was 4 x 10⁹ to 6 x 10¹⁰ pfu/gm of donor heart. Transfer was confirmed by DNA amplification for both genes. Gene product expression in tissue was quantified by immunoassay and visualized by immunohistochemical staining. Results: Allograft viral uptake was only 9.9% ± 2.4% with bolus injection, but increased to 80.5% ± 6.8% at 1 ml/min infusion rate (p = 5 x 10^–14). Uptake ratio was not affected by vector quantity or slower infusion rates. Transforming growth factor–ß₁ was consistently detected in allografts infected with AdCMVTGF-ß₁, but not with control adenovirus or AdSvIL10. Expression was proportional to infused vector quantity and reached 10 ng/gm of allograft at infused 10¹⁰ pfu/gm. Transforming growth factor–ß₁ was also detected in recipient's serum at less than 1 ng/ml. Viral interleukin-10 was detected in minor amounts only (<1 ng/gm) in allografts infected with AdvIL10 up to 5 x 10¹⁰ pfu/gm. Nevertheless, it was detected in recipient serum at concentrations up to 0.4 ng/ml. Conclusions: Intracoronary gene transfer of immunosuppressive cytokines to cardiac allografts during cold preservation is feasible. Slow infusion is superior to bolus injection. In vivo effects on allograft rejection remain to be determined.

This article has been cited by other articles:

				A. S. Shah, D. C. White, O. Tai, J. A. Hata, K. H. Wilson, A. Pippen, A. P. Kypson, D. D. Glower, R. J. Lefkowitz, and W. J. Koch Adenovirus-mediated genetic manipulation of the myocardial {beta}-adrenergic signaling system in transplanted hearts J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 581 - 588. [Abstract] [Full Text] [PDF]

				C. Pellegrini, A. Jeppsson, C. B. Taner, T. O’Brien, V. M. Miller, H. D. Tazelaar, and C. G. A. McGregor HIGHLY EFFICIENT EX VIVO GENE TRANSFER TO THE TRANSPLANTED HEART BY MEANS OF HYPOTHERMIC PERFUSION WITH A LOW DOSE OF ADENOVIRAL VECTOR J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 493 - 500. [Abstract] [Full Text] [PDF]

				M. D. Allen Myocardial protection: is there a role for gene therapy? Ann. Thorac. Surg., November 1, 1999; 68(5): 1924 - 1928. [Abstract] [Full Text] [PDF]

				M. Hein, M. Ernst, F. Moller, and D. Regensburger Gene transfer into rat heart-derived endothelial cells Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 460 - 466. [Abstract] [Full Text] [PDF]